Abstract
We mailed a survey on treatment practices for transient hypothyroxinemia of prematurity (THOP) to 100 randomly selected neonatologists. In the year before the survey, 13 of 62 respondents (21.0%) had treated an average of 4.5 THOP patients with thyroid hormone, and 3 had treated 10 or more patients. Randomized trials assessing the value of thyroid supplementation in THOP are urgently needed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Notes
The seven survey questions.
-
1
Do you ever treat premature infants with transient hypothyroxinemia of prematurity with any type of thyroid hormone?
-
2
In the past 12 months, how many premature infants have you treated for transient hypothyroxinemia?
-
3
Do you treat infants with transient hypothyroxinemia of prematurity with T4 only?
-
4
Have you ever used T3 in treating infants with transient hypothyroxinemia of prematurity?
-
5
At what age have you generally initiated treatment for infants with transient hypothyroxinemia of prematurity?
-
6
At what level of serum total thyroxine would you consider treatment of transient hypothyroxinemia of prematurity necessary, assuming no elevation of TSH?
-
7
Have you ever consulted a pediatric endocrinologist for advice in management of premature infants with transient hypothyroxinemia?
-
1
References
Reuss ML, Leviton A, Paneth N, Susser M . Thyroxine values from newborn screening of 919 infants born before 29 weeks' gestation Am J Public Health 1997 87: 10 1693–7 also NEJM letter
Reuss ML, Paneth N, Pinto-Martin JA, Lorenz JM, Susser M . The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age N Engl J Med 1996 334: 821–7
den Ouden AL, Kok JH, Verkerk PH, Brand R, Verloove-Vanhorick SP . The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birthweight infants Pediatr Res 1996 39: 142–5
Lucas A, Rennie J, Baker BA, Morley R . Low plasma triiodothyronine concentrations and outcome in preterm infants Arch Dis Child 1988 63: 1201–6
Lucas A, Morley R, Fewtrell MS . Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up BMJ 1996 312: 1132–3
Rapaport R, Rose SR, Freemark M . Hypothyroxinemia in the preterm infant: the benefits and risks of thyroxine treatment J Pediatr 2001 139: 2 182–8
United States Neonatologists and Perinatologists Directory. Section on Perinatal Pediatrics — AAP — CD 1998
Schonberger W, Grimm W, Emmrich P et al. Reduction in mortality rate in premature infants by substitution of thyroid hormones Eur J Pediatr 1981 135: 245–53
Chowdry P, Scanlon JW, Auerbach R, Abassi V . Results of a controlled double-blind study of thyroid replacement in very-low-birth-weight premature infants with hypothyroxinemia Pediatrics 1984 73: 301–5
Vanhole C, Aerssens P, Naulaers G et al. L-Thyroxine treatment of preterm newborns: clinical and endocrine effects Pediatr Res 1997 42: 87–92
Van Wassenaer AG, Kok JH, Endert E et al. Effects of thyroxine supplementation on neurological development in infants born at less than 30 weeks gestation N Engl J Med 1997 336: 21–6
Osborn DA . Thyroid hormones for preventing neurodevelopmental impairment in preterm infants Cochrane Database Syst Rev 2001 4 CD001070
Amato M, Pasquier S, Carasso A, van Muralt G . Postnatal thyroxine administration for idiopathic respiratory distress syndrome in premature infants Horm Res 1988 29: 27–30
Amato M, Guggisberg C, Schneider H . Postnatal triiodothyronine replacement and respiratory distress syndrome of the preterm infant Horm Res 1989 32: 213–7
Acknowledgements
Wen-Jiang Fu PhD, Assistant Professor of Epidemiology, Michigan State University, designed and executed the sampling procedure. Lora McAdams and Jian-Ping He, MD, MS, assisted in data entry, management, and analysis.
Author information
Authors and Affiliations
Additional information
Presented in part at the ESPR meeting, Greenwich, CT, March 2002 and at the APS/SPR meeting, Baltimore, May 2002.
Rights and permissions
About this article
Cite this article
Golombek, S., LaGamma, E. & Paneth, N. Treatment of Transient Hypothyroxinemia of Prematurity: A Survey of Neonatal Practice. J Perinatol 22, 563–565 (2002). https://doi.org/10.1038/sj.jp.7210791
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7210791
This article is cited by
-
Hypothyroxinemia in extremely low birth weight infants
Italian Journal of Pediatrics (2015)
-
Indomethacin Use for the Management of Patent Ductus Arteriosus in Preterms: A Web-Based Survey of Practice Attitudes Among Neonatal Fellowship Program Directors in the United States
Pediatric Cardiology (2007)